Cardiovascular Diseases

Qualified Health Claim for High Oleic Acid Oils

The U.S. Food and Drug Administration (FDA) responded to a petition for a new qualified health claim for edible oils containing high levels of oleic acid, a monounsaturated fat that’s been shown to have cardiovascular benefits when it replaces heart-damaging saturated fat. Manufacturers of these oils can choose to include a qualified health claim on their label stating that “supportive but not conclusive scientific evidence suggests that daily consumption of about 1½ tablespoons (20 grams) of oils containing high levels of oleic acid, may reduce the risk of coronary heart disease.” The claim will also need to make it clear that to achieve this benefit, these oils “should replace fats and oils higher in saturated fat and not increase the total number of calories you eat in a day.” Edible oils must contain at least 70 percent oleic acid to meet the criteria for this qualified health claim. Specific edible oils include: high oleic sunflower oil, high oleic safflower oil, high oleic canola oil, olive oil and high oleic algal oil. Some high oleic oils will not degrade when heated to high temperatures, which makes them ideal to use for baking or frying. The science behind the new qualified health claim for oleic acid, while not conclusive, is promising. Importantly, there is no study found that eating oleic acid-containing oils had beneficial heart effects unless they replaced other types of fats and oils higher in saturated fats in the diet. Source: https://www.fda.gov/

hyangiu

Recent Posts

ACS Updates Prostate Cancer Screening Guidance

The American Cancer Society (ACS) concludes that the benefits of PSA-based screening for prostate cancer…

22 hours ago

Proton Pump Inhibitor Use Linked to Dementia Risk in Older Adults

Proton pump inhibitor (PPI) use was modestly associated with incident dementia in older adults (pooled…

2 days ago

Long-Term Outcomes of Invasive vs Conservative Management in Stable Coronary Disease: Consistent Evidence From Extended Follow-Up Trials

Extended follow-up of three major trials consistently shows that an initial invasive strategy does not…

3 days ago

Antidepressants Differ in Efficacy and Acceptability in Long-Term Treatment of Major Depressive Disorder

Escitalopram, duloxetine, and agomelatine achieved higher sustained response rates than fluoxetine, while escitalopram and duloxetine…

3 days ago

Intensive BP Control Reduces Cardiovascular Events After Ischemic Stroke

Targeting a systolic blood pressure (BP) of less than 120 mm Hg lowered the incidence…

6 days ago

No Significant Reduction in Major Cardiovascular Events with Intensive BP Lowering in T2D

In patients with type 2 diabetes (T2D) and high cardiovascular risk, targeting a systolic blood…

6 days ago

This website uses cookies.